Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.
2.

Risk of Bias in Systematic Reviews of Non-Randomized Studies of Adverse Cardiovascular Effects of Thiazolidinediones and Cyclooxygenase-2 Inhibitors: Application of a New Cochrane Risk of Bias Tool.

Bilandzic A, Fitzpatrick T, Rosella L, Henry D.

PLoS Med. 2016 Apr 5;13(4):e1001987. doi: 10.1371/journal.pmed.1001987. eCollection 2016 Apr.

3.

A Comprehensive Updated Review of Pharmaceutical and Nonpharmaceutical Treatment for NAFLD.

Hossain N, Kanwar P, Mohanty SR.

Gastroenterol Res Pract. 2016;2016:7109270. doi: 10.1155/2016/7109270. Epub 2016 Feb 23. Review.

4.

Cardiovascular risk associated with the use of glitazones, metformin and sufonylureas: meta-analysis of published observational studies.

Pladevall M, Riera-Guardia N, Margulis AV, Varas-Lorenzo C, Calingaert B, Perez-Gutthann S.

BMC Cardiovasc Disord. 2016 Jan 15;16:14. doi: 10.1186/s12872-016-0187-5.

5.

Prescription Stimulant Use and Hospitalization for Psychosis or Mania: A Population-Based Study.

Cressman AM, Macdonald EM, Huang A, Gomes T, Paterson MJ, Kurdyak PA, Mamdani MM, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

J Clin Psychopharmacol. 2015 Dec;35(6):667-71. doi: 10.1097/JCP.0000000000000406.

6.

Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada.

Eibl JK, Gomes T, Martins D, Camacho X, Juurlink DN, Mamdani MM, Dhalla IA, Marsh DC.

J Addict Med. 2015 Nov-Dec;9(6):440-6. doi: 10.1097/ADM.0000000000000156.

7.

Tight glycemic control and cardiovascular effects in type 2 diabetic patients.

Moodahadu LS, Dhall R, Zargar AH, Bangera S, Ramani L, Katipally R.

Heart Views. 2014 Oct-Dec;15(4):111-20. doi: 10.4103/1995-705X.151084. Review.

8.

Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.

Zipursky J, Macdonald EM, Hollands S, Gomes T, Mamdani MM, Paterson JM, Lathia N, Juurlink DN.

PLoS Med. 2014 Sep 30;11(9):e1001736. doi: 10.1371/journal.pmed.1001736. eCollection 2014 Sep.

9.

The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies.

Varas-Lorenzo C, Margulis AV, Pladevall M, Riera-Guardia N, Calingaert B, Hazell L, Romio S, Perez-Gutthann S.

BMC Cardiovasc Disord. 2014 Sep 26;14:129. doi: 10.1186/1471-2261-14-129. Review.

10.

Treating the elderly diabetic patient: special considerations.

Kezerle L, Shalev L, Barski L.

Diabetes Metab Syndr Obes. 2014 Aug 28;7:391-400. doi: 10.2147/DMSO.S48898. eCollection 2014. Review.

11.

Health promotion or pharmacological treatment for chronic diseases?

Allam MF, Arjona O.

J Prev Med Hyg. 2013 Mar;54(1):11-3. Review.

12.

Diuretics prevent thiazolidinedione-induced cardiac hypertrophy without compromising insulin-sensitizing effects in mice.

Chang CS, Tsai PJ, Sung JM, Chen JY, Ho LC, Pandya K, Maeda N, Tsai YS.

Am J Pathol. 2014 Feb;184(2):442-53. doi: 10.1016/j.ajpath.2013.10.020. Epub 2013 Nov 26.

13.

Statins and the risk of herpes zoster: a population-based cohort study.

Antoniou T, Zheng H, Singh S, Juurlink DN, Mamdani MM, Gomes T.

Clin Infect Dis. 2014 Feb;58(3):350-6. doi: 10.1093/cid/cit745. Epub 2013 Nov 13. Erratum in: Clin Infect Dis. 2014 Apr;58(8):1203.

14.

STAT3 signaling in pulmonary arterial hypertension.

Paulin R, Meloche J, Bonnet S.

JAKSTAT. 2012 Oct 1;1(4):223-33. doi: 10.4161/jkst.22366. Review.

15.

Comparative effectiveness of angiotensin-receptor blockers for preventing macrovascular disease in patients with diabetes: a population-based cohort study.

Antoniou T, Camacho X, Yao Z, Gomes T, Juurlink DN, Mamdani MM.

CMAJ. 2013 Sep 3;185(12):1035-41. doi: 10.1503/cmaj.121771. Epub 2013 Jul 8.

16.

Risk of incident diabetes among patients treated with statins: population based study.

Carter AA, Gomes T, Camacho X, Juurlink DN, Shah BR, Mamdani MM.

BMJ. 2013 May 23;346:f2610. doi: 10.1136/bmj.f2610. Erratum in: BMJ. 2013;347:f4356.

17.

Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3?

de Lorgeril M, Salen P, Defaye P, Rabaeus M.

BMC Med. 2013 Jan 4;11:5. doi: 10.1186/1741-7015-11-5.

18.

Rates of hemorrhage during warfarin therapy for atrial fibrillation.

Gomes T, Mamdani MM, Holbrook AM, Paterson JM, Hellings C, Juurlink DN.

CMAJ. 2013 Feb 5;185(2):E121-7. doi: 10.1503/cmaj.121218. Epub 2012 Nov 26.

19.

Effects of funding policy changes and health warnings on the use of erythropoiesis-stimulating agents.

Weir MA, Gomes T, Winquist E, Juurlink DN, Cuerden MS, Mamdani M.

J Oncol Pract. 2012 May;8(3):179-83. doi: 10.1200/JOP.2011.000287. Epub 2012 Jan 17.

20.

Fluoroquinolone therapy and idiosyncratic acute liver injury: a population-based study.

Paterson JM, Mamdani MM, Manno M, Juurlink DN; Canadian Drug Safety and Effectiveness Research Network.

CMAJ. 2012 Oct 2;184(14):1565-70. doi: 10.1503/cmaj.111823. Epub 2012 Aug 13.

Items per page

Supplemental Content

Write to the Help Desk